Company / Return on Equity (ROE)
BIODESIX INC Return on Equity (ROE) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-205.7%
FY2024
5-year range
-1138.6% / -205.7%
FY2020-FY2024
Trend
+81.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
BIODESIX INC reports negative total equity of -205.7% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-205.7% in FY2024 with a 3-year CAGR of +13.1%.
Improved from -317.6% to -205.7% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +13.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on equity (roe) increased 81.9% year-over-year.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -4.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -205.7% | +81.9% |
| FY2023 | -1138.6% | -258.5% |
| FY2022 | -317.6% | -45.2% |
| FY2021 | -218.8% | -37.6% |
| FY2020 | -159.0% | - |
As of FY2024 · SEC Form 10-K · Last checked Jun 21, 2026